Article archive / September 2023
Originally published: . Volume 14, No. 9. Source pages: 6.
Researchers published, "COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State," in the journal Cureus, in August.
Juan J. Chamie, Data Analysis, Independent Data Analyst, Cambridge, USA, Jennifer A. Hibberd, Faculty of Dentistry, University of Toronto, Toronto, CAN, and David E. Scheim, Commissioned Corps, Inactive Reserve, United States Public Health Service, Blacksburg, USA, found a 74% reduction in deaths in the geographical areas that had the most intensive ivermectin use against Covid-19, in Peru.
The researchers noted, "Reductions in excess deaths over a period of 30 days after peak deaths averaged 74% in the 10 states with the most intensive IVM use. As determined across all 25 states, these reductions in excess deaths correlated closely with the extent of IVM use (p<0.002). During four months of IVM use in 2020, before a new president of Peru restricted its use, there was a 14-fold reduction in nationwide excess deaths and then a 13-fold increase in the two months following the restriction of IVM use. Notably, these trends in nationwide excess deaths align with WHO summary data for the same period in Peru.
"To evaluate possible IVM treatment effects, excess deaths as determined from Peruvian national health data were analyzed by state for ages ≥60 in Peru’s 25 states. These data were compared with monthly summary data for excess deaths in Peru for the period 2020-2021 as published by the WHO in 2022. To identify potential confounding factors, Google mobility data, population densities, SARS-CoV-2 genetic variations, and seropositivity rates were also examined."
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.